Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hypertension

  Free Subscription


07.05.2018

1 Biochem Biophys Res Commun
1 Circulation
1 Curr Opin Nephrol Hypertens
5 Hypertension
1 J Am Soc Hypertens
7 J Hum Hypertens
1 PLoS Med
2 PLoS One
1 Stroke


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Biochem Biophys Res Commun

  1. ZHANG B, Nakata M, Lu M, Nakae J, et al
    Protective role of AgRP neuron's PDK1 against salt-induced hypertension.
    Biochem Biophys Res Commun. 2018 Apr 30. pii: S0006-291X(18)30989.
    PubMed     Text format     Abstract available


    Circulation

  2. DE LA SIERRA A, Banegas JR, Vinyoles E, Segura J, et al
    Prevalence of Masked Hypertension in Untreated and Treated Patients With Office Blood Pressure Below 130/80 mm Hg.
    Circulation. 2018 Apr 30. pii: CIRCULATIONAHA.118.034619.
    PubMed     Text format     Abstract available


    Curr Opin Nephrol Hypertens

  3. GEORGIANOS PI, Agarwal R
    Blood pressure in hemodialysis: targets?
    Curr Opin Nephrol Hypertens. 2017 Aug 21. doi: 10.1097/MNH.0000000000000359.
    PubMed     Text format     Abstract available


    Hypertension

  4. AKHABUE E, Montag S, Reis JP, Pool LR, et al
    FGF23 (Fibroblast Growth Factor-23) and Incident Hypertension in Young and Middle-Aged Adults: The CARDIA Study (Coronary Artery Risk Development in Young Adults).
    Hypertension. 2018 Apr 30. pii: HYPERTENSIONAHA.118.11060.
    PubMed     Text format     Abstract available

  5. SHARMA RK, Oliveira AC, Kim S, Rigatto K, et al
    Involvement of Neuroinflammation in the Pathogenesis of Monocrotaline-Induced Pulmonary Hypertension.
    Hypertension. 2018 Apr 30. pii: HYPERTENSIONAHA.118.10934.
    PubMed     Text format     Abstract available

  6. DONAT-VARGAS C, Akesson A, Tornevi A, Wennberg M, et al
    Persistent Organochlorine Pollutants in Plasma, Blood Pressure, and Hypertension in a Longitudinal Study.
    Hypertension. 2018 Apr 30. pii: HYPERTENSIONAHA.117.10691.
    PubMed     Text format     Abstract available

  7. WU WH, Yuan P, Zhang SJ, Jiang X, et al
    Impact of Pituitary-Gonadal Axis Hormones on Pulmonary Arterial Hypertension in Men.
    Hypertension. 2018 Apr 30. pii: HYPERTENSIONAHA.118.10963.
    PubMed     Text format     Abstract available

  8. KARIO K
    Nocturnal Hypertension: New Technology and Evidence.
    Hypertension. 2018 Apr 30. pii: HYPERTENSIONAHA.118.10971.
    PubMed     Text format    


    J Am Soc Hypertens

  9. TOUYZ RM, Herrmann SMS, Herrmann J
    Vascular toxicities with VEGF inhibitor therapies-focus on hypertension and arterial thrombotic events.
    J Am Soc Hypertens. 2018 Mar 21. pii: S1933-1711(18)30076.
    PubMed     Text format     Abstract available


    J Hum Hypertens

  10. KASIAKOGIAS A, Tsioufis C, Dimitriadis K, Konstantinidis D, et al
    Cardiovascular morbidity of severe resistant hypertension among treated uncontrolled hypertensives: a 4-year follow-up study.
    J Hum Hypertens. 2018 May 1. pii: 10.1038/s41371-018-0065.
    PubMed     Text format     Abstract available

  11. SALAZAR MR, Espeche WG, Stavile RN, Balbin E, et al
    Could self-measured office blood pressure be a hypertension screening tool for limited-resources settings?
    J Hum Hypertens. 2018 May 1. pii: 10.1038/s41371-018-0057.
    PubMed     Text format     Abstract available

  12. KAIHARA T, Imaizumi Y, Eguchi K, Kario K, et al
    Maximum home blood pressure readings are associated with left atrial diameter in essential hypertensives.
    J Hum Hypertens. 2018 May 1. pii: 10.1038/s41371-018-0060.
    PubMed     Text format     Abstract available

  13. ZHAO A, Tan S, Szeto IM, Wang Y, et al
    Gaps in awareness and control of hypertension: a cross-sectional study in Chinese urban adults.
    J Hum Hypertens. 2018 May 1. pii: 10.1038/s41371-018-0059.
    PubMed     Text format     Abstract available

  14. VISCO V, Finelli R, Pascale AV, Mazzeo P, et al
    Difficult-to-control hypertension: identification of clinical predictors and use of ICT-based integrated care to facilitate blood pressure control.
    J Hum Hypertens. 2018 May 1. pii: 10.1038/s41371-018-0063.
    PubMed     Text format     Abstract available

  15. SHANTSILA A, Shantsila E, Gill PS, Lip GYH, et al
    Predictors of diastolic dysfunction in ethnic groups: observations from the Hypertensive Cohort of The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES).
    J Hum Hypertens. 2018 May 1. pii: 10.1038/s41371-018-0064.
    PubMed     Text format     Abstract available

  16. WANG G, Chen Y, Li L, Tang W, et al
    First-line renin-angiotensin system inhibitors vs. other first-line antihypertensive drug classes in hypertensive patients with type 2 diabetes mellitus.
    J Hum Hypertens. 2018 May 1. pii: 10.1038/s41371-018-0066.
    PubMed     Text format     Abstract available


    PLoS Med

  17. OGEDEGBE G, Plange-Rhule J, Gyamfi J, Chaplin W, et al
    Health insurance coverage with or without a nurse-led task shifting strategy for hypertension control: A pragmatic cluster randomized trial in Ghana.
    PLoS Med. 2018;15:e1002561.
    PubMed     Text format     Abstract available


    PLoS One

  18. BRADBURY K, Morton K, Band R, van Woezik A, et al
    Using the Person-Based Approach to optimise a digital intervention for the management of hypertension.
    PLoS One. 2018;13:e0196868.
    PubMed     Text format     Abstract available

  19. TESHOME DF, Demssie AF, Zeleke BM
    Determinants of blood pressure control amongst hypertensive patients in Northwest Ethiopia.
    PLoS One. 2018;13:e0196535.
    PubMed     Text format     Abstract available


    Stroke

  20. LAN J, Esposito E, Ayata C, Singhal AB, et al
    Different Effects of Normobaric Oxygen in Normotensive Versus Hypertensive Rats After Focal Cerebral Ischemia.
    Stroke. 2018 Apr 30. pii: STROKEAHA.118.020626.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: